Eimeria mitis (E. mitis)

Eimeria mitis is a protozoan parasite belonging to the phylum Apicomplexa and is one of the seven Eimeria species that cause coccidiosis in chickens [1]. It primarily colonizes the lower small intestine, including the ileum and sometimes the large intestine, where it replicates within the host's mucosal epithelial cells [2]. Although it is generally characterized by low pathogenicity compared to species like Eimeria tenella, E. mitis infections can lead to significant economic losses due to reduced weight gain and poor feed conversion ratios in broiler chickens [4]. Management of the parasite typically involves the use of coccidiostats, such as ionophores (e.g., monensin) and synthetic chemicals (e.g., amprolium), or the administration of live-attenuated vaccines [3]. As an entire organism, Eimeria mitis represents a pathogen rather than a specific molecular target, though its various enzymes and transporters serve as the actual sites of action for anticoccidial drugs [1]. The parasite's life cycle includes both asexual (schizogony) and sexual (gametogony) phases, culminating in the production of environmentally resistant oocysts [2]. Drug resistance is a major challenge in the poultry industry, necessitating the rotation of different classes of anticoccidials [3]. Modern diagnostic techniques, including quantitative PCR, are used to distinguish E. mitis from other morphologically similar species in mixed infections [4].

Anticoccidial agents act by disrupting ion transport across parasite membranes (ionophores), inhibiting thiamine uptake (amprolium), or interfering with mitochondrial respiration and nuclear division (triazines) [3].